Neogenomics (NEO) Restructuring Costs (2022 - 2024)

Neogenomics (NEO) has 3 years of Restructuring Costs data on file, last reported at $1.7 million in Q4 2024.

• Quarterly Restructuring Costs rose 41.66% year-over-year to $1.7 million in Q4 2024, while the trailing twelve-month figure through Mar 2025 was $4.3 million (down 51.6% YoY) and the FY2024 annual result came in at $6.7 million, down 39.95% from the prior year.
• Restructuring Costs climbed to $1.7 million in Q4 2024, from $1.0 million in the prior quarter.
• In the past five years, Restructuring Costs ranged from a high of $4.7 million in Q1 2023 to a low of $1.0 million in Q3 2024.
• A 3-year average of $2.5 million and a median of $2.1 million in 2023 frame the typical range for Restructuring Costs.
• Annual changes were most pronounced in 2023 — Restructuring Costs sank 73.32% — and 2024, when it soared 41.66%.
• Tracing NEO's Restructuring Costs over 3 years: stood at $4.5 million in 2022, then slumped by 73.32% to $1.2 million in 2023, then surged by 41.66% to $1.7 million in 2024.
• The last three Restructuring Costs figures came in at $1.7 million (Q4 2024), $1.0 million (Q3 2024), and $1.5 million (Q2 2024), per Business Quant data.